Downloading...
Download

RSLS

822% in 1 day from 0.36 to 3.32 that's current state of market🚨 822% in 1 day from 0.36 to 3.32 that’s the current state of how wild things are in the stock market 🔥 NASDAQ:RSLS Lots of opportunities out there 👀 but as always you MUST take profit along the way, these mostly low quality stocks exploding on news which might be real or not, exploding on shortsellers getting trapped and squeezed. When the party is over they usually slide all the way down where they came from so you need to be smart and take profits. 800% in a day is enough, no need to be greedy for more and get surprised with drop saying the news company previously released is unverified or the offering company does overnight.
NASDAQ:RSLS
by ProfitTradeRoom
ReShape Lifesciences ($RSLS) Up 68% Yesterday but Down TodayKey Takeaway 1. ReShape Lifesciences (RSLS) stock rosed on Wednesday on an U.S. Food and Drug Administration (FDA) update. 2. The company got a PMA supplement for its Lap-Band 2.0 FLEX. That news brings with it heavy trading of RSLS shares. ReShape Lifesciences (NASDAQ:RSLS) stock is rosed higher on Wednesday following approval from the U.S. Food and Drug Administration (FDA) for a PMA supplement. That PMA supplement applies to the company’s Lap-Band 2.0 FLEX. This is the company’s minimally invasive, long-term treatment of obesity. What This Means for RSLS Stock Improvement of its weight loss product is a positive for ReShape Lifesciences. The FDA approval also puts its product closer to market, which could mean more revenue for the company. With this news comes heavy trading of RSLS stock. As of this writing, around 50 million shares have changed hands. That’s a massive leap in trading volume compared to the company’s daily average of about 4 million shares. Despite the rapid 68% Rapid Surge, NASDAQ:RSLS plummeted in price with the stock trading at 0.3614 (-5.98%) as of the time of writing. If NASDAQ:RSLS should test the Support level at $0.2990, we should expect a continual trend or a reversal trend.
NASDAQ:RSLS
by DEXWireNews
RSLS Short Term Retracement Still Showing LevelsOnly did the fib retracement back til July because before that the levels are just absurdly higher. So sticking to some level of relevance, we can start to see what areas have materialized as potentially "important" in my opinion. For RSLS , the 786 fib has been a level of high traffic and pivot for the stock. It was previous support back in July and into August, then turned into resistance ever since. Similar to Kosmos, ReShape hasn’t released much recent news. However, a new VP of Operations and R&D in August along with more substantial revenues for the quarter have been two things traders have focused on. Furthermore, insider buying from CFO Thomas Stankovich this summer came as a vote of confidence for some. Stankovich picked up nearly $50,000 worth of RSLS stock toward the end of August. However, the company has presented at several industry events and was given a notice of allowance by the US Patent & Trademark Office titled “Intragastric Device” late last month. RSLS Stock Forecast According to the World Health Organization, worldwide obesity has nearly tripled since 1975. With an ever-growing population, there remains a constant need for helping those hit by this disease. This week Maxim Group initiated coverage on ReShape with a Buy rating and a price target 167% higher than retail levels on October 8th. Maxim joins other analysts like Alliance Global, who also has a hefty price target on RSLS stock . It sits at $10.25 or roughly 290% higher than where RSLS opened on Friday.
NASDAQ:RSLS
by PennyStocks101
2
RSLS ReShape Lifesciences Price Target- ReShape leader in weight loss market - FDA approved Lap-Band manufacturing moved to the US - eliminated debt overhang - ReShape Marketplace - digital health solution June 30, 2021: Cash and cash equivalents and restricted cash were $40.2 million. ReShape Market Cap only 50.061M Shares Outstanding 17.20M On 7/1/2021, Ben Haynor from Alliance Global Partners brokerage Lowered the Price Target from $18.50 to $13.75 My price target is the 9.6usd resistance. I`m looking forward to read your opinion about RSLS.
NASDAQ:RSLSLong
by TopgOptions
7
RSLS ReShape Lifesciences Global Weight-Loss Leader | $ TargetOn 6/17/2021 Alliance Global Partners brokerage Boosted the Price Target for RSLS ReShape Lifesciences stock from $12.00 to $18.50! ReShape Lifesciences is America's premier weight-loss solutions company. The FDA-approved Lap-Band® program provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The ReShape Vest™ System is an investigational (outside the U.S.) minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery. Reshapecare™ virtual health coaching program is a virtual telehealth weight management program that supports lifestyle changes for all weight-loss patients, to help them keep the weight off over time. (accesswire.com) My price target is 12usd short term.
NASDAQ:RSLSLong
by TopgOptions
7